Trump said you could learn something from this man

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Brian Hansen Biography and Net Worth

EVP of Tandem Diabetes Care

Brian Hansen has served as our Executive Vice President and Chief Commercial Officer since February 2016. Prior to joining our Company, Mr. Hansen served from September 2014 as Chief Commercial Officer of Adaptive Biotechnologies Corp. From May 2013 to September 2014, Mr. Hansen served as Head of Commercial, Sales and Marketing, of Genoptix, a Novartis Company. From December 2005 to February 2013, he served in various roles of increasing responsibility at Gen-Probe, Inc., a medical diagnostics company, most recently serving as Senior Vice President, Global Sales and Services from January 2012 to February 2013. Mr. Hansen received a BS in Business Administration from the University of Missouri-Columbia, and an MBA from the School of Business at San Diego State University.

What is Brian B. Hansen's net worth?: The estimated net worth of Brian B. Hansen is at least $548,063.55 as of October 7th, 2020. Mr. Hansen owns 19,665 shares of Tandem Diabetes Care stock worth more than $548,064 as of November 20th. This net worth approximation does not reflect any other investments that Mr. Hansen may own. Additionally, Mr. Hansen receives a salary of $561,740.00 as EVP at Tandem Diabetes Care. Learn More about Brian B. Hansen's net worth.
How old is Brian B. Hansen?: Mr. Hansen is currently 56 years old. There are 7 older executives and no younger executives at Tandem Diabetes Care. The oldest executive at Tandem Diabetes Care is Mr. John F. Sheridan, President, CEO & Director, who is 69 years old. Learn More on Brian B. Hansen's age.
What is Brian B. Hansen's salary?: As the EVP of Tandem Diabetes Care, Inc., Mr. Hansen earns $561,740.00 per year. The highest earning executive at Tandem Diabetes Care is Mr. John F. Sheridan, President, CEO & Director, who commands a salary of $988,350.00 per year. Learn More on Brian B. Hansen's salary.
How do I contact Brian B. Hansen?: The corporate mailing address for Mr. Hansen and other Tandem Diabetes Care executives is 11075 ROSELLE STREET, San Diego CA, 92121. Tandem Diabetes Care can also be reached via phone at (858) 366-6900 and via email at [email protected]. Learn More on Brian B. Hansen's contact information.
Has Brian B. Hansen been buying or selling shares of Tandem Diabetes Care?: Brian B. Hansen has not been actively trading shares of Tandem Diabetes Care within the last three months. Learn More on Brian B. Hansen's trading history.
Who are Tandem Diabetes Care's active insiders?: Tandem Diabetes Care's insider roster includes David Berger (EVP), Kim Blickenstaff (Director), Elizabeth Gasser (EVP), Brian Hansen (EVP), James Leal (SVP), Kathleen McGroddy-Goetz (Director), Susan Morrison (EVP), Rebecca Robertson (Director), John Sheridan (CEO), Christopher Twomey (Director), and Leigh Vosseller (CFO). Learn More on Tandem Diabetes Care's active insiders.
Are insiders buying or selling shares of Tandem Diabetes Care?: In the last twelve months, Tandem Diabetes Care insiders bought shares 2 times. They purchased a total of 5,532 shares worth more than $107,163.68. In the last twelve months, insiders at the medical device company sold shares 1 times. They sold a total of 5,000 shares worth more than $258,400.00. The most recent insider tranaction occured on November, 15th when EVP Mark David Novara bought 532 shares worth more than $12,363.68. Insiders at Tandem Diabetes Care own 2.2% of the company. Learn More about insider trades at Tandem Diabetes Care.
Information on this page was last updated on 11/15/2024.

Brian B. Hansen Insider Trading History at Tandem Diabetes Care

Brian B. Hansen Buying and Selling Activity at Tandem Diabetes Care

Tandem Diabetes Care Company Overview

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Today's Range

Now: $27.87

$27.66

$28.60

50 Day Range

MA: $37.19

$27.34

$45.44

2 Week Range

Now: $27.87

$17.33

$53.69

Volume

1,344,288 shs

Average Volume

1,604,687 shs

Market Capitalization

$1.83 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36

Trump said you could learn something from this man

From Wide Moat Research | Ad

Here’s everything you need to know.

Brian Hansen Biography and Net Worth

What is Brian B. Hansen's net worth?

How old is Brian B. Hansen?

What is Brian B. Hansen's salary?

How do I contact Brian B. Hansen?

Has Brian B. Hansen been buying or selling shares of Tandem Diabetes Care?

Who are Tandem Diabetes Care's active insiders?

Are insiders buying or selling shares of Tandem Diabetes Care?